Podcast

Examining Major Breakthroughs Made in Breast Cancer in Milwaukee

Author(s):

We traveled to Milwaukee, Wisconsin, for a State of the Science Summit™ on Breast Cancer, which featured insights from key thought leaders at Carbone Cancer Center of the University of Wisconsin.

We recently traveled to Milwaukee, Wisconsin, for a State of the Science Summit™ on Breast Cancer. At the meeting, faculty from Carbone Cancer Center of the University of Wisconsin highlighted the evolving paradigms across breast cancer subtypes and settings, such as early and advanced hormone receptor—positive breast cancer, early-stage HER2-positive breast cancer, and metastatic triple-negative breast cancer.

Related Videos
Kelly E. McCann, MD, PhD, assistant professor, breast medical oncologist, UCLA
5 experts are featured in this series
5 experts are featured in this series
Julie Lang, MD, discusses real-world outcomes of the neoadjuvant KEYNOTE-522 regimen in patients with early-stage triple-negative breast cancer.
2 experts are featured in this series.
2 experts are featured in this series.
Ian Krop MD, PhD